Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 3/20 | 0.34 |
| ▸ | ACP3 | P15309 | 2/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2003043 | 0.80 | MIF (0.38) | MIFCYP2D6LMNA | |
| SCHEMBL5694065 | 0.74 | MIF (0.31) | MIF | |
| SCHEMBL2870631 | 0.72 | MIF (0.38) | MIFCYP2D6SRCLMNAMAPK1 | |
| SCHEMBL27678513 | 0.72 | DPP4 (0.33) | ACP3 | |
| SCHEMBL43325 | 0.72 | SRC (0.42) | MIFCYP2D6SRCLMNAMAPK1 | |
| SCHEMBL165792 | 0.72 | MIF (0.40) | MIFCYP2D6SRCLMNAMAPK1 | |
| SCHEMBL20146 | 0.72 | MIF (0.40) | MIFCYP2D6SRCLMNAMAPK1 | |
| SCHEMBL134389 | 0.72 | MIF (0.40) | MIFCYP2D6SRCLMNAMAPK1 | |
| SCHEMBL27749125 | 0.70 | MIF (0.39) | MIFCYP2D6SRCLMNAMAPK1 | |
| SCHEMBL1205494 | 0.70 | MIF (0.39) | MIFCYP2D6SRCLMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011331-A | Preparation method of high-hydrophobicity corrosion-resistant fluorine-containing polyurea material | 沈阳化工大学 | 2026-05-12 | — | — | CN | disclosed |
| WO-2021074279-A1 | SPIRO-FUSED TRICYCLIC MAP4K1 INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2021-04-22 | — | — | WO | disclosed |
| EP-1490340-A1 | HETEROAROMATIC UREA DERIVATIVES AS VR-1 RECEPTOR MODULATORS FOR TREATING PAIN | MERCK SHARP & DOHME LTD. (GB) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003080578-A1 | HETEROAROMATIC UREA DERIVATIVES AS VR-1 RECEPTOR MODULATORS FOR TREATING PAIN | MERCK SHARP & DOHME LIMITED (GB) | 2003-10-02 | — | — | WO | disclosed |
| EP-0362001-B1 | N-CYCLOALKYL BENZYLAMINES ALPHA,ALPHA DISUBSTITUTED, THE PROCESS FOR THEIR PREPARATION, THEIR USE AS DRUGS AND THEIR SYNTHESIS INTERMEDIATES | JOUVEINAL S.A. (FR) | 1993-03-10 | — | — | EP | disclosed |
| EP-0362001-A1 | N-cycloalkyl benzylamines alpha,alpha disubstituted, the process for their preparation, their use as drugs and their synthesis intermediates | JOUVEINAL S.A. (FR) | 1990-04-04 | — | — | EP | disclosed |